Ayodeji A. Asuni

New York University, New York, NY, United States 
Neuroscience, Immunotherapy, Prion, Alzheimer's Disease
"Ayodeji Asuni"
Mean distance: 21.58 (cluster 51)
Cross-listing: Alzheimer's Tree

BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Clement A, Wiborg O, Asuni AA. (2020) Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer's Disease: Insights From Preclinical Models, Clinical Data, and Future Directions. Frontiers in Aging Neuroscience. 12: 56
Bastrup J, Kastaniegaard K, Asuni AA, et al. (2019) Proteomic and Unbiased Post-Translational Modification Profiling of Amyloid Plaques and Surrounding Tissue in a Transgenic Mouse Model of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Pitera AP, Asuni AA, O'Connor V, et al. (2019) Pathogenic tau does not drive activation of the unfolded protein response. The Journal of Biological Chemistry
Pankiewicz JE, Asuni AA, Reich C, et al. (2019) P2-056: TARGETING APP TRANSLATION FOR ALZHEIMER'S DISEASE THERAPY Alzheimer's & Dementia. 15: P592-P593
Rosenqvist N, Asuni AA, Andersson CR, et al. (2018) Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau. Alzheimer's & Dementia (New York, N. Y.). 4: 521-534
Sumner IL, Edwards RA, Asuni AA, et al. (2018) Antibody Engineering for Optimized Immunotherapy in Alzheimer's Disease. Frontiers in Neuroscience. 12: 254
Clement A, Mitchelmore C, Andersson DR, et al. (2017) Cerebrospinal fluid neurofilament light chain as a biomarker of neurodegeneration in the Tg4510 and MitoPark mouse models. Neuroscience. 354: 101-109
Pankiewicz JE, Asuni AA, Baquero-Buitrago J, et al. (2017) [P2-060]: CHARACTERIZATION OF A SMALL-MOLECULE APP TRANSLATION INHIBITOR FOR ALZHEIMER's DISEASE PREVENTION AND THERAPY Alzheimer's & Dementia. 13: P627-P628
Clement A, Mitchelmore C, Andersson D, et al. (2016) P2-103: Altered Expression Levels of Neurofilaments in Brain and CSF in TG4510 and Mitopark MICE Alzheimer's & Dementia. 12: P651-P651
Asuni AA, Guridi M, Sanchez S, et al. (2015) Antioxidant peroxiredoxin 6 protein rescues toxicity due to oxidative stress and cellular hypoxia in vitro, and attenuates prion-related pathology in vivo. Neurochemistry International. 90: 152-65
See more...